rhodioloside has been researched along with Kidney Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, W; Li, W; Pei, T; Wang, L; Xiao, W; Yan, S; Yang, S; Zeng, Y | 1 |
Guo, Y; Li, R; Yan, T; Zhang, X; Zhang, Y; Zhu, L | 1 |
Huang, X; Liu, Y; Ma, J; Qin, X; Sun, C; Xue, H; Zhang, J; Zhang, Y | 1 |
Gao, YW; Tang, L; Wang, ZC; Wei, RB; Xing, Y; Yang, Y; Zheng, XY | 1 |
4 other study(ies) available for rhodioloside and Kidney Diseases
Article | Year |
---|---|
Salidroside Alleviates Renal Fibrosis in SAMP8 Mice by Inhibiting Ferroptosis.
Topics: Animals; Ferroptosis; Fibrosis; Glucosides; Kidney Diseases; Mice | 2022 |
Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways.
Topics: Cadherins; Cell Line; Cytokines; Epithelial-Mesenchymal Transition; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; MAP Kinase Signaling System; NF-kappa B; Phenols; Rhodiola; Toll-Like Receptor 4 | 2019 |
Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity.
Topics: Animals; Antibiotics, Antineoplastic; beta Catenin; Doxorubicin; Gene Expression Regulation; Glucosides; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Phenols; Podocytes; Proteinuria; Signal Transduction | 2019 |
Protective effect of salidroside on contrast-induced nephropathy in comparison with N-acetylcysteine and its underlying mechanism.
Topics: Acetylcysteine; Animals; Contrast Media; Cytoprotection; Glucosides; Kidney; Kidney Diseases; Oxidative Stress; Phenols; Rats; Rats, Wistar; Signal Transduction | 2015 |